BeStock  
Stocks › Biotechnology › INSM

Insmed INSM

US equityMarket cap rank #631Biotechnology
$141.33 −$3.13 (-2.17%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $142.81 +1.05%
Open$143.27
Prev close$144.46
Day range$140.99 – $150.00
Volume6.22M
Market cap$31.01B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-50.3x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average -12.7x

Price / book42.7x
CheapRich

Above its usual level · 77th percentile, 5-year average 30.0x

#5265 of 5338 stocks by PB (1 = cheapest)

Price / sales20.4x
CheapRich

Around its usual level · 53rd percentile, 5-year average 29.4x

#4762 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-54x-36x-18x0xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$155.58
Price vs. fair value-9.2%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 42.70 – 30.01 77% (pricier than usual) #5265 of 5338 (1 = cheapest)
PE -50.30 -1,549.49 -12.67 0% (cheaper than usual) –
PS 20.40 11.31 29.38 53% (pricier than usual) #4762 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on INSM.

Sign in to join the discussion.

Scroll to Top